Personalized brain stimulation for fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether personalized, non-invasive brain stimulation (TMS) can help improve fat metabolism and reduce liver damage in people with a form of fatty liver disease linked to both metabolism and moderate alcohol intake. It may offer a new treatment option without medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of fatty liver disease linked to metabolism (MASLD) and drink moderate amounts of alcohol (20-60 grams per day).
- You are between 18 and 65 years old.
- Your body mass index (BMI) is above 24.
- You have no history of alcohol abuse.
- You do not have any conditions that would make MRI or TMS unsafe (like metal implants or certain health issues).
- You are not pregnant, breastfeeding, or planning pregnancy, and have not had TMS treatment in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of brain stimulation that uses gentle electrical currents to target the part of the brain linked to alcohol cravings. It may help people with alcohol use disorder reduce their drinking.
This study uses a brain stimulation technique called TMS combined with MRI scans to treat alcohol use disorder. It aims to see if targeting specific brain connections can help reduce drinking.
This study tests whether a new type of brain stimulation, guided by MRI and a robot, can help reduce heavy drinking in people with alcohol use disorder. The treatment is non-invasive and aims to improve brain function related to cravings.
This trial tests whether high-frequency rTMS (a non-surgical brain stimulation) can reduce how much alcohol you drink. It targets people with alcohol use disorder who are not fully stopping, and who want to cut down after a past relapse or failed withdrawal attempt.
This trial tests a type of noninvasive brain stimulation to see if it can reduce drinking and related “wanting” to drink. It may help people with alcohol use disorder who are currently drinking heavily.
This trial tests a non-invasive brain stimulation device (Deep TMS) to help people with alcohol use disorder reduce or stop heavy drinking. It uses magnetic pulses to target brain areas linked to addiction.
Hear when a new Fatty Liver trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.